TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31898647

Group type: EXPERIMENTAL
Intervention: PEG‐LD 25 mg/m2 and docetaxel 50 mg/m2
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PEG‐LD 30 mg/m2 and docetaxel 50 mg/m2
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PEG‐LD 30 mg/m2 and docetaxel 60 mg/m2
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: PEG‐LD and docetaxel regimen
Number of subjects: 5
Study: 30675151

Group type: EXPERIMENTAL
Intervention: Acute exercise (EG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 38
Study: 27703344

Group type: EXPERIMENTAL
Intervention: Higher dose (HD) of Fluticasone 1,000 μg/day
Number of subjects: 248
Study: 23888466

Group type: EXPERIMENTAL
Intervention: Prebiotic mixture (neutral and acidic oligosaccharides)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 22240800

Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin (C-PLD)
Number of subjects: 976

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (C-P)
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: CA-125 progression
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: CA-125 first progression
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: CA-125 or radiological first progression
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Symptomatic first progression
Number of subjects: 976
Study: 20009095

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 982

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 982

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 982
Study: 18669966

Group type: EXPERIMENTAL
Intervention: Holland nail
Number of subjects: 190

Group type: COMPARATOR
Intervention: DHS
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 190
Study: 15933396

Group type: EXPERIMENTAL
Intervention: Verbal pain scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Horizontal visual pain scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Vertical visual pain scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Faces pain scale
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Self-assessment scales (all four)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Observational pain rating scale
Number of subjects: 160
Study: 12868184

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg once daily for 30 days
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Fenofibrate 200 mg once daily for 30 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (11 clinically healthy persons aged 21-54 years)
Number of subjects: 35
Study: 10372724

Group type: EXPERIMENTAL
Intervention: Calcium infusion (1.1 mg calcium gluconate/cc in 5% dextrose at a rate of 4 cc/kg x h) (n = 7)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Human PTH-(1-34) infusion (0.55 U/kg x h) (n = 9)
Number of subjects: 16
Study: 8501265

Group type: EXPERIMENTAL
Intervention: Baclofen as protective therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 39
Study: 3123603

Group type: EXPERIMENTAL
Intervention: L‐deprenyl
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromocriptine
Number of subjects: 0
Study: 29752998

Group type: EXPERIMENTAL
Intervention: High protein group (HP) - 35 g of protein after training sessions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Low protein group (LP) - 35 g of placebo after training sessions
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 27758940

Group type: EXPERIMENTAL
Intervention: Intraoperative computerized tomographic image‐guided endoscopic surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Medical control (MISTIE trial)
Number of subjects: 20
Study: 26406063

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV) at 25Hz for 4 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no vibration) performing the same exercise as WBV group
Number of subjects: 20
Study: 22691263

Group type: EXPERIMENTAL
Intervention: NOP‐47 (5 g)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: NOP‐47
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 21624138

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 40
Study: 19781472

Group type: EXPERIMENTAL
Intervention: Femtosecond laser (IntraLase, 30 or 60 kHz)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Mechanical microkeratome (Hansatome)
Number of subjects: 183
Study: 16423671

Group type: EXPERIMENTAL
Intervention: Myocardial contrast echocardiography (MCE)
Number of subjects: 50
Study: 15239204

Group type: EXPERIMENTAL
Intervention: Prefitting hearing aid orientation (HAO) counseling
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postfitting hearing aid orientation (HAO) counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: No counseling
Number of subjects: 0
Study: 11764222

Group type: EXPERIMENTAL
Intervention: Social support and education
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 600

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 600
Study: 10093820

Group type: EXPERIMENTAL
Intervention: Children with headache and CTS
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (52 sex- and age-matched children with headache without EEG abnormalities)
Number of subjects: 32
Study: 7925334

Group type: COMPARATOR
Intervention: bupivacaine 0.167% alone
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: sufentanil 2 micrograms ml‐1 (5 micrograms h‐1) in 0.167% bupivacaine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: sufentanil 4 micrograms ml‐1 (10 micrograms h‐1) in 0.167% bupivacaine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: sufentanil 4 micrograms ml‐1 (10 micrograms h‐1) in normal saline
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: sufentanil without bupivacaine
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: sufentanil 5 micrograms h‐1
Number of subjects: 171
Study: 2572412

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 1190685

Group type: EXPERIMENTAL
Intervention: Postoperative intraperitoneal lavage with antibiotics
Number of subjects: 155

Group type: COMPARATOR
Intervention: Postoperative drainage without lavage, systemic antibiotics
Number of subjects: 155
Study: 31613172

Group type: EXPERIMENTAL
Intervention: Kinesio Taping + Balance Exercises (KT+BE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo Kinesio Taping + Balance Exercises (KTp+BE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Kinesio Taping (KT) alone
Number of subjects: 44
Study: 27168463

Group type: EXPERIMENTAL
Intervention: S-flurbiprofen plaster (SFPP)
Number of subjects: 633

Group type: COMPARATOR
Intervention: Flurbiprofen (FP) patch
Number of subjects: 633
Study: 24977699

Group type: EXPERIMENTAL
Intervention: Water-based exercise
Number of subjects: 15

Group type: COMPARATOR
Intervention: Land-based exercise
Number of subjects: 15
Study: 23233136

Group type: EXPERIMENTAL
Intervention: lidocaine + metoclopramide (10 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: lidocaine + ketamine (5 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: lidocaine (20 mg)
Number of subjects: 90
Study: 21518592

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/d)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study: 19006748

Group type: EXPERIMENTAL
Intervention: Sharp-edged intraocular lenses (IOLs)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Round-edged intraocular lenses (IOLs)
Number of subjects: 26
Study: 16835999

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LFD) (20-25% of energy content)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: High-fat diet (HFD) (40-45% of energy content)
Number of subjects: 44
Study: 12949426

Group type: EXPERIMENTAL
Intervention: Bicalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 11121907

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg once daily
Number of subjects: 96

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg twice daily
Number of subjects: 96
Study: 9100593

Group type: EXPERIMENTAL
Intervention: recombinant human IGF-I (rhIGF-I) therapy (80 micrograms.kg.day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Insulin therapy alone
Number of subjects: 43
Study: 8112546

Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal endoscopy without sedation
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal endoscopy with sedation using i.v. midazolam at a dosage of 0.05 mg/kg
Number of subjects: 65
Study: 3595668

Group type: EXPERIMENTAL
Intervention: Adriamycin (20 mg/week)
Number of subjects: 128

Group type: COMPARATOR
Intervention: VAC (vincristine, Adriamycin and cyclophosphamide)
Number of subjects: 128
Study: 29671383

Group type: EXPERIMENTAL
Intervention: Basketball intervention group (6-week programme)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Basketball control group
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Soccer intervention group
Number of subjects: 87
Study: 27225729

Group type: EXPERIMENTAL
Intervention: Dairy yogurt supplemented with rhamnogalacturonan (RG) - 150 mL daily containing 50 mg of probiotics and 100 mg of hallabong peel polysaccharide (60% RG) for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo group - same product without hallabong peel supplement for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups (test and placebo)
Number of subjects: 120
Study: 24184850

Group type: EXPERIMENTAL
Intervention: Core Position and Control movement strategy (Core‐PAC) warm‐up
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard warm-up
Number of subjects: 20
Study: 21748368

Group type: EXPERIMENTAL
Intervention: 6% CHO-E solution
Number of subjects: 7

Group type: COMPARATOR
Intervention: 2% CHO-E solution
Number of subjects: 7

Group type: COMPARATOR
Intervention: 10% CHO-E solution
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: All carbohydrate concentrations
Number of subjects: 7
Study: 20300897

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 18823182

Group type: EXPERIMENTAL
Intervention: Volitional help sheet
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control conditions (Questionnaire‐only; questionnaire plus planning instruction; questionnaire, planning instruction plus volitional help sheet without explicit instruction)
Number of subjects: 193
Study: 16060184

Group type: EXPERIMENTAL
Intervention: Protease-modulating matrix (Promogran)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional dressings
Number of subjects: 80
Study: 12422579

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + amoxycillin 1000 mg (RBCCA)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate 400 mg + clarithromycin 500 mg + metronidazole 500 mg (RBCCM)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Omeprazole 20 mg + clarithromycin 500 mg + amoxycillin 1000 mg (OCA)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Omeprazole 20 mg + clarithromycin 500 mg + metronidazole 500 mg (OCM)
Number of subjects: 256
Study: 10325898

Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: COMPARATOR
Intervention: Guanosine 5'-monophosphate (GMP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-allergic controls after AMP
Number of subjects: 18
Study: 9122012

Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment in group I (61 patients with glomerular disease at diagnosis)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment in group II (24 patients with restrained disease activity)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment in group III (14 patients with active glomerulopathy)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: CIC and UIC detection
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Histological findings related to UC3
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Histological findings related to CIC
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Urinary excretion of IC
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Simultaneous excretion of C4 in urine
Number of subjects: 99
Study: 1745621

Group type: EXPERIMENTAL
Intervention: 500-mg ETA suppository
Number of subjects: 12

Group type: COMPARATOR
Intervention: 250-mg ETA tablets
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo suppository
Number of subjects: 12

Group type: COMPARATOR
Intervention: Two placebo tablets
Number of subjects: 12
Study: 7035987

Group type: EXPERIMENTAL
Intervention: Propranolol (320 mg given in 8 doses over a period of 24 hours)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Frusemide (40 mg)
Number of subjects: 9
Study: 30684965

Group type: EXPERIMENTAL
Intervention: Curcumin plus placebo (CC)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Long-chain omega-3 polyunsaturated fatty acids plus placebo (FO)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Curcumin plus long-chain omega-3 polyunsaturated fatty acids (CC-FO)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Double placebo (PL)
Number of subjects: 64
Study: 28320856

Group type: EXPERIMENTAL
Intervention: Baroreflex activation therapy
Number of subjects: 383
Study: 25403347

Group type: EXPERIMENTAL
Intervention: Medical yoga
Number of subjects: 159

Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 159

Group type: COMPARATOR
Intervention: Self-care advice
Number of subjects: 159
Study: 24014831

Group type: EXPERIMENTAL
Intervention: AMG 145 (420 mg subcutaneously every 4 weeks for ≥12 weeks, then every 2 weeks for an additional 12 weeks)
Number of subjects: 8
Study: 21636687

Group type: EXPERIMENTAL
Intervention: Written Emotional Disclosure (WED)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Time management narratives
Number of subjects: 31
Study: 19684298

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Patellar tendon autograft
Number of subjects: 64
Study: 17228169

Group type: EXPERIMENTAL
Intervention: Immunotherapy with standardized, aluminum hydroxide‐adsorbed J. ashei extract (100 IR, 54 microg of Jun a 1/ml)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 14706600

Group type: EXPERIMENTAL
Intervention: Surgical skills laboratory course on CVC (n = 12)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Traditional group (n = 14)
Number of subjects: 26
Study: 11330757

Group type: EXPERIMENTAL
Intervention: Endurance training using arm-propelled three-wheeled chair (APTWC) for 12 weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 12
Study: 9578793

Group type: EXPERIMENTAL
Intervention: Ballard method (external criteria only)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dubowitz method
Number of subjects: 0
Study: 8484655

Group type: EXPERIMENTAL
Intervention: Argon laser treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: Dye laser treatment
Number of subjects: 85
Study: 3434348

Group type: EXPERIMENTAL
Intervention: Chloramphenicol treatment continued after negative cultures
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chloramphenicol treatment withdrawn after negative cultures
Number of subjects: 24
Study: 31255494

Group type: EXPERIMENTAL
Intervention: Cognitively Normal (CN) participants with higher plasma Aβ1‐42 levels
Number of subjects: 2840

Group type: EXPERIMENTAL
Intervention: Cognitively Normal (CN) participants
Number of subjects: 2840

Group type: EXPERIMENTAL
Intervention: Mild Cognitive Impairment (MCI) participants
Number of subjects: 2840
Study: 29095133

Group type: EXPERIMENTAL
Intervention: Guided self-help CBT (GSH-CBT)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Face-to-face CBT
Number of subjects: 396

Group type: COMPARATOR
Intervention: Continued Guided self-help CBT (GSH)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Stepped care model (GSH followed by face-to-face CBT for non-responders)
Number of subjects: 396
Study: 27792719

Group type: EXPERIMENTAL
Intervention: Maggot debridement therapy (MDT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Surgical debridement and topical application of silver sulfadiazine (SSD)
Number of subjects: 19
Study: 25523578

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) treatment for 1 week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM) treatment for 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: OVA-challenged 1 week
Number of subjects: 50

Group type: COMPARATOR
Intervention: OVA-challenged 2 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal control
Number of subjects: 50
Study: 22646167

Group type: EXPERIMENTAL
Intervention: CAO + S (simvastatin 20 mg)
Number of subjects: 113

Group type: COMPARATOR
Intervention: CAO + P (placebo)
Number of subjects: 113
Study: 20621700

Group type: COMPARATOR
Intervention: Standard duration therapy (24 weeks)
Number of subjects: 268

Group type: COMPARATOR
Intervention: Variable duration therapy (VD12 for 12 weeks and VD24 for 24 weeks)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Variable duration therapy (VD12 for 12 weeks)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Variable duration therapy (VD24 for 24 weeks)
Number of subjects: 268
Study: 17826201

Group type: EXPERIMENTAL
Intervention: Active TSE treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Sham TSE treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Active and Sham TSE treatments
Number of subjects: 58
Study: 15780157

Group type: EXPERIMENTAL
Intervention: Screening for prostate cancer (PSA test)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no screening)
Number of subjects: 0
Study: 12886046

Group type: EXPERIMENTAL
Intervention: Conventional membrane and LDL apheresis (group C)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vitamin E-coated membrane and LDL apheresis (group D)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional cellulose or synthetic membranes (group A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Vitamin E-coated membrane (group B)
Number of subjects: 30
Study: 10578484

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (350 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: RRR-alpha-tocopherol (250 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Beta-carotene (60 mg)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Selenium (80 micrograms as sodium selenite)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (350 mg) + RRR-alpha-tocopherol (250 mg)
Number of subjects: 21
Study: 8722735

Group type: EXPERIMENTAL
Intervention: Preemptive, multimodal analgesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pain intensity at 24 hours after surgery (rest and after movement)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: McGill Pain Questionnaire data at 24 and 48 hours
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Patient-controlled morphine consumption (mg)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pain thresholds to pressure applied to a rib contralateral to the incision
Number of subjects: 30
Study: 1914760

Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg by mouth 2 hr before the start)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 6350957

Group type: EXPERIMENTAL
Intervention: 0.5 g of ornidazole
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1.0 g of ornidazole
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 1.5 g of ornidazole
Number of subjects: 59
Study: 30508633

Group type: EXPERIMENTAL
Intervention: Lactobacillus Rhamnosus GG (LGG)
Number of subjects: 61

Group type: COMPARATOR
Intervention: No probiotics (Control)
Number of subjects: 61
Study: 28270284

Group type: EXPERIMENTAL
Intervention: Saline flush at 3.0 ml/s (40 ml) - Group A
Number of subjects: 68

Group type: COMPARATOR
Intervention: Saline flush at 4.0 ml/s (40 ml) - Group B
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 68
Study: 26846324

Group type: EXPERIMENTAL
Intervention: DHA supplementation (50 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (standard neonatal nutrition)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: DHA supplementation and placebo
Number of subjects: 60
Study: 23750967

Group type: EXPERIMENTAL
Intervention: Perspective change of 45°
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perspective change > 45°
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speed of rotation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Asymmetric polyhedrons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slant
Number of subjects: 0
Study: 22391417

Group type: EXPERIMENTAL
Intervention: Educational baby books
Number of subjects: 167

Group type: COMPARATOR
Intervention: Non-educational baby books
Number of subjects: 167

Group type: COMPARATOR
Intervention: No books
Number of subjects: 167
Study: 20660695

Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (healthy controls from North America)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rifampin (in patients with SLCO1B1 genotype c.463CA)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Rifampin (in patients with SLCO1B1 genotype c.463CC)
Number of subjects: 72
Study: 17674476

Group type: EXPERIMENTAL
Intervention: Combined antiviral therapy (CAT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Basic treatment (control group)
Number of subjects: 32
Study: 16639914

Group type: EXPERIMENTAL
Intervention: P-100 device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meniett device
Number of subjects: 0
Study: 12637183

Group type: EXPERIMENTAL
Intervention: Serial casting for 5 weeks
Number of subjects: 10